CUSIP No. 232674507

13G

Page 1 of 19 Pages

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

SCHEDULE 13G

(AMENDMENT No. 2)

 

UNDER THE SECURITIES EXCHANGE ACT OF 1934 1

 

Point Therapeutics, Inc.

(Name of Issuer)

 

Common Stock

(Title of Class of Securities)

 

730694106

(CUSIP Number)

 

December 31, 2007

(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

o Rule 13d-1(b)

x Rule 13d-1(c)

o Rule 13d-1(d)

 

_________________

 

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes ).

 

 


CUSIP No. 232674507

13G

Page 2 of 19 Pages

 

 

 

1.

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

ProQuest Investments, L.P.                04-3428180

 

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP**

(a)

o

(b)

x

3.

SEC USE ONLY

 

4.

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

 

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH

5.

SOLE VOTING POWER

-0-

6.

SHARED VOTING POWER

-0-

7.

SOLE DISPOSITIVE POWER

-0-

8.

SHARED DISPOSITIVE POWER

-0-

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

-0-

10.

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES**

o

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

0%

12.

TYPE OF REPORTING PERSON**

PN

 

** SEE INSTRUCTIONS BEFORE FILLING OUT

 

 


CUSIP No. 232674507

13G

Page 3 of 19 Pages

 

 

1.

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

ProQuest Companion Fund, L.P.                04-3428725

 

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP**

(a)

o

(b)

x

4.

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

 

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH

5.

SOLE VOTING POWER

-0-

6.

SHARED VOTING POWER

-0-

7.

SOLE DISPOSITIVE POWER

-0-

8.

SHARED DISPOSITIVE POWER

-0-

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

-0-

10.

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES**

o

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

0%

12.

TYPE OF REPORTING PERSON**

PN

 

** SEE INSTRUCTIONS BEFORE FILLING OUT

 

 


CUSIP No. 232674507

13G

Page 4 of 19 Pages

 

 

1.

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

ProQuest Investments II, L.P.                22-3764772

 

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP**

(a)

o

(b)

x

3.

SEC USE ONLY

 

4.

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

 

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH

5.

SOLE VOTING POWER

-0-

6.

SHARED VOTING POWER

-0-

7.

SOLE DISPOSITIVE POWER

-0-

8.

SHARED DISPOSITIVE POWER

-0-

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

-0-

10.

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES**

o

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

0%

12.

TYPE OF REPORTING PERSON**

PN

 

** SEE INSTRUCTIONS BEFORE FILLING OUT

 

 


CUSIP No. 232674507

13G

Page 5 of 19 Pages

 

 

1.

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

ProQuest Investments II Advisors Fund, L.P.              22-3784567

 

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP**

(a)

o

(b)

x

3.

SEC USE ONLY

 

4.

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

 

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH

5.

SOLE VOTING POWER

-0-

6.

SHARED VOTING POWER

-0-

7.

SOLE DISPOSITIVE POWER

-0-

8.

SHARED DISPOSITIVE POWER

-0-

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

-0-

10.

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES**

o

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

0%

12.

TYPE OF REPORTING PERSON **

PN

 

** SEE INSTRUCTIONS BEFORE FILLING OUT

 

 


CUSIP No. 232674507

13G

Page 6 of 19 Pages

 

 

1.

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

ProQuest Associates LLC                04-3428185

 

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP**

(a)

o

(b)

x

3.

SEC USE ONLY

 

4.

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

 

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH

5.

SOLE VOTING POWER

-0-

6.

SHARED VOTING POWER

-0-

7.

SOLE DISPOSITIVE POWER

-0-

8.

SHARED DISPOSITIVE POWER

-0-

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

-0-

10.

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES**

o

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

0%

12.

TYPE OF REPORTING PERSON **

OO*

 

** SEE INSTRUCTIONS BEFORE FILLING OUT

 

 


CUSIP No. 232674507

13G

Page 7 of 19 Pages

 

 

1.

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

ProQuest Associates II LLC                22-3764735

 

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP**

(a)

o

(b)

x

3.

SEC USE ONLY

 

4.

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

 

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH

5.

SOLE VOTING POWER

-0-

6.

SHARED VOTING POWER

-0-

7.

SOLE DISPOSITIVE POWER

-0-

8.

SHARED DISPOSITIVE POWER

-0-

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

-0-

10.

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES**

o

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

0%

12.

TYPE OF REPORTING PERSON **

OO

 

** SEE INSTRUCTIONS BEFORE FILLING OUT

 

 


CUSIP No. 232674507

13G

Page 8 of 19 Pages

 

 

1.

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

Jay Moorin

 

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP**

(a)

o

(b)

x

3.

SEC USE ONLY

 

4.

CITIZENSHIP OR PLACE OF ORGANIZATION

United States

 

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH

5.

SOLE VOTING POWER

-0-

6.

SHARED VOTING POWER

-0-

7.

SOLE DISPOSITIVE POWER

-0-

8.

SHARED DISPOSITIVE POWER

-0-

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

-0-

10.

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES**

o

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

0%

12.

TYPE OF REPORTING PERSON **

IN

 

** SEE INSTRUCTIONS BEFORE FILLING OUT

 

 


CUSIP No. 232674507

13G

Page 9 of 19 Pages

 

 

1.

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

Alain Schreiber

 

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP**

(a)

o

(b)

x

3.

SEC USE ONLY

 

4.

CITIZENSHIP OR PLACE OF ORGANIZATION

United States Resident Alien

 

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH

5.

SOLE VOTING POWER

-0-

6.

SHARED VOTING POWER

-0-

7.

SOLE DISPOSITIVE POWER

-0-

8.

SHARED DISPOSITIVE POWER

-0-

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

-0-

10.

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES**

o

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

0%

12.

TYPE OF REPORTING PERSON **

IN

 

** SEE INSTRUCTIONS BEFORE FILLING OUT

 

 


CUSIP No. 232674507

13G

Page 10 of 19 Pages

 

 

1.

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

Joyce Tsang

 

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP**

(a)

o

(b)

x

3.

SEC USE ONLY

 

4.

CITIZENSHIP OR PLACE OF ORGANIZATION

United States

 

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH

5.

SOLE VOTING POWER

-0-

6.

SHARED VOTING POWER

-0-

7.

SOLE DISPOSITIVE POWER

-0-

8.

SHARED DISPOSITIVE POWER

-0-

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

-0-

10.

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES**

o

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

0%

12.

TYPE OF REPORTING PERSON **

IN

 

** SEE INSTRUCTIONS BEFORE FILLING OUT

 

 


CUSIP No. 232674507

13G

Page 11 of 19 Pages

 

 

1.

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

Pasquale DeAngelis

 

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP**

(a)

o

(b)

x

3.

SEC USE ONLY

 

4.

CITIZENSHIP OR PLACE OF ORGANIZATION

United States

 

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH

5.

SOLE VOTING POWER

-0-

6.

SHARED VOTING POWER

-0-

7.

SOLE DISPOSITIVE POWER

-0-

8.

SHARED DISPOSITIVE POWER

-0-

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

-0-

10.

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES**

o

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

0%

12.

TYPE OF REPORTING PERSON **

IN

 

** SEE INSTRUCTIONS BEFORE FILLING OUT

 

 


CUSIP No. 232674507

13G

Page 12 of 19 Pages

 

 

Item 1(a).

Name of Issuer.

Point Therapeutics, Inc. (the “Company”).

Item 1(b).

Address of Issuer’s Principal Executive Offices.

The Company’s principal executive offices are located at 70 Walnut Street, Wellesley Hills, Massachusetts 02481.

Items 2(a).

Name of Person Filing.

This statement is filed on behalf of the following persons with respect to shares of common stock of the Company and warrants to purchase shares of common stock of the Company purchased by such persons (collectively, the “Shares”) pursuant to that certain Subscription Agreement, dated October 2, 2003:

(i)        ProQuest Investments, L.P., a Delaware limited partnership (“Investments”), with respect to Shares beneficially owned by it;

(ii)       ProQuest Companion Fund, L.P., a Delaware limited partnership (“Companion Fund”), with respect to Shares beneficially owned by it;

(iii)      ProQuest Investments II, L.P., a Delaware limited partnership (“Investments II”), with respect to Shares beneficially owned by it;

(iv)      ProQuest Investments II Advisors Fund, L.P., a Delaware limited partnership (“Advisors Fund”), with respect to Shares beneficially owned by it;

(v)       ProQuest Associates LLC, a Delaware limited liability company (“Associates”), as General Partner of Investments and Companion Fund, with respect to Shares beneficially owned by Investments and Companion Fund;

(vi)      ProQuest Associates II LLC, a Delaware limited liability company (“Associates II”), as General Partner of Investments II and Advisors Fund, with respect to Shares beneficially owned by Investments II and Advisors Fund;

(vii)     Jay Moorin, an individual and a member of Associates and Associates II (“Moorin”), with respect to Shares beneficially owned by Investments, Companion Fund, Investments II and Advisors Fund;

(viii)    Alain Schreiber, an individual and a member of Associates and Associates II (“Schreiber”), with respect to Shares beneficially owned by Investments, Companion Fund, Investments II and Advisors Fund;

(ix)      Joyce Tsang, an individual and a member of Associates and Associates II (“Tsang”), with respect to Shares beneficially owned by Investments, Companion Fund, Investments II and Advisors Fund; and

 


CUSIP No. 232674507

13G

Page 13 of 19 Pages

 

 

(xi)      Pasquale DeAngelis, an individual and a member of Associates and Associates II (“DeAngelis”), with respect to Shares beneficially owned by Investments, Companion Fund, Investments II and Advisors Fund.

The foregoing persons are hereinafter are referred to collectively as the “Reporting Persons.” Any disclosures herein with respect to persons other than the Reporting Persons are made on information and belief after making inquiry to the appropriate party.

Item 2(b).

Address of Principal Business Office or, if None, Residence.

The address of the principal business office of each of the Reporting Persons is 90 Nassau Street, 5th Floor, Princeton, NJ 08542.

Item 2(c).

Citizenship.

Mr. Moorin, Ms. Tsang and Mr. DeAngelis are United States citizens. Mr. Schreiber is a United States resident alien. Investments, Companion Fund, Investments II and Advisors Fund are Delaware limited partnerships organized under the laws of the State of Delaware. Associates and Associates II are Delaware limited liability companies organized under the laws of the State of Delaware.

Item 2(d).

Title of Class of Securities.

Common stock, par value $0.01 per share.

Item 2(e).

CUSIP Number.

730694106.

Item 3.

If this statement is filed pursuant to Rules 13d-1(b) or 13d- 2(b) or (c), check whether the person filing is a:

 

(a)

o

Broker or dealer registered under Section 15 of the Act,

(b)

o

Bank as defined in Section 3(a)(6) of the Act,

(c)

o

Insurance Company as defined in Section 3(a)(19) of the Act,

(d)

o

Investment Company registered under Section 8 of the Investment Company Act of 1940,

(e)

o

Investment Adviser in accordance with Rule 13d-1 (b)(1)(ii)(E),

(f)

o

Employee Benefit Plan or Endowment Fund in accordance with 13d-1 (b)(1)(ii)(F),

 

 


CUSIP No. 232674507

13G

Page 14 of 19 Pages

 

 

 

(g)

o

Parent Holding Company or control person in accordance with Rule 13d-1 (b)(1)(ii)(G),

(h)

o

Savings Association as defined in Section 3(b) of the Federal Deposit Insurance Act,

(i)

o

Church Plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940,

(j)

o

Group, in accordance with Rule 13d-1(b)(1)(ii)(J).

 

Item 4.

Ownership.

The percentages used herein are calculated based upon 39,312,000 shares issued and outstanding as of November 6, 2007, based upon the Quarterly Report of the Company for the quarter ended September 30, 2007. As of the close of business on December 31, 2007, the Reporting Persons owned shares of the Company’s common stock in the amounts and percentages listed below:

 

A.

ProQuest Investments, L.P.

(a)

Amount beneficially owned: -0-

(b)

Percent of class: 0%

(c)

(i)

Sole power to vote or direct the vote: -0-

 

(ii)

Shared power to vote or direct the vote: -0-

 

(iii)

Sole power to dispose or direct the disposition: -0-

 

(iv)

Shared power to dispose or direct the disposition: -0-

B.

ProQuest Companion Fund, L.P.

(a)

Amount beneficially owned: -0-

(b)

Percent of class: 0%

(c)

(i)

Sole power to vote or direct the vote: -0-

 

(ii)

Shared power to vote or direct the vote: -0-

 

(iii)

Sole power to dispose or direct the disposition: -0-

 

(iv)

Shared power to dispose or direct the disposition: -0-

 

 


CUSIP No. 232674507

13G

Page 15 of 19 Pages

 

 

 

C.

ProQuest Investments II, L.P.

(a)

Amount beneficially owned: -0-

(b)

Percent of class: -0-%

(c)

(i)

Sole power to vote or direct the vote: -0-

 

(ii)

Shared power to vote or direct the vote: -0-

 

(iii)

Sole power to dispose or direct the disposition: -0-

 

(iv)

Shared power to dispose or direct the disposition: -0-

D.

ProQuest Investments II Advisors Fund, L.P.

(a)

Amount beneficially owned: -0-

(b)

Percent of class: 0%

(c)

(i)

Sole power to vote or direct the vote: -0-

 

(ii)

Shared power to vote or direct the vote: -0-

 

(iii)

Sole power to dispose or direct the disposition: -0-

 

(iv)

Shared power to dispose or direct the disposition: -0-

E.

ProQuest Associates LLC

(a)

Amount beneficially owned: -0-

(b)

Percent of class: 0%

(c)

(i)

Sole power to vote or direct the vote: -0-

 

(ii)

Shared power to vote or direct the vote: -0-

 

(iii)

Sole power to dispose or direct the disposition: -0-

 

(iv)

Shared power to dispose or direct the disposition: -0-

F.

ProQuest Associates II LLC

(a)

Amount beneficially owned: -0-

(b)

Percent of class: 0%

 

 


CUSIP No. 232674507

13G

Page 16 of 19 Pages

 

 

 

(c)

(i)

Sole power to vote or direct the vote: -0-

 

(ii)

Shared power to vote or direct the vote: -0-

 

(iii)

Sole power to dispose or direct the disposition: -0-

 

(iv)

Shared power to dispose or direct the disposition: -0-

G.

Jay Moorin

(a)

Amount beneficially owned: -0-

(b)

Percent of class: 0%

(c)

(i)

Sole power to vote or direct the vote: -0-

 

(ii)

Shared power to vote or direct the vote: -0-

 

(iii)

Sole power to dispose or direct the disposition: -0-

 

(iv)

Shared power to dispose or direct the disposition: -0-

H.

Alain Schreiber

(a)

Amount beneficially owned: -0-

(b)

Percent of class: 0%

(c)

(i)

Sole power to vote or direct the vote: -0-

 

(ii)

Shared power to vote or direct the vote: -0-

 

(iii)

Sole power to dispose or direct the disposition: -0-

 

(iv)

Shared power to dispose or direct the disposition: -0-

I.

Joyce Tsang

(a)

Amount beneficially owned: -0-

(b)

Percent of class: 0%

(c)

(i)

Sole power to vote or direct the vote: -0-

 

(ii)

Shared power to vote or direct the vote: -0-

 

(iii)

Sole power to dispose or direct the disposition: -0-

 

 


CUSIP No. 232674507

13G

Page 17 of 19 Pages

 

 

 

 

(iv)

Shared power to dispose or direct the disposition: -0-

J.

Pasquale DeAngelis

(a)

Amount beneficially owned: -0-

(b)

Percent of class: 0%

(c)

(i)

Sole power to vote or direct the vote: -0-

 

(ii)

Shared power to vote or direct the vote: -0-

 

(iii)

Sole power to dispose or direct the disposition: -0-

 

(iv)

Shared power to dispose or direct the disposition: -0-

 

Item 5.

Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following.     x

Item 6.

Ownership of More than Five Percent on Behalf of Another Person.

To the knowledge of the Reporting Persons, no other person has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, a number of the Shares which represents more than five percent of the number of outstanding shares of the Shares.

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.

Not Applicable.

Item 8.

Identification and Classification of Members of the Group.

Not Applicable.

Item 9.

Notice of Dissolution of Group.

Not Applicable.

Item 10.

Certifications.

Each of the Reporting Persons hereby makes the following certification:

 


CUSIP No. 232674507

13G

Page 18 of 19 Pages

 

 

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

DATED: February 8, 2008

 

 

/s/ Pasquale DeAngelis

 

Pasquale DeAngelis, individually, as a member of ProQuest Associates LLC and ProQuest Associates II LLC, as a member of ProQuest Associates LLC on behalf of ProQuest Investments, L.P. and ProQuest Companion Fund, L.P., and as a member of ProQuest Associates II LLC on behalf of ProQuest Investments II, L.P. and ProQuest Investments II Advisors Fund, L.P.

 

 

 

 

 

*

 

Jay Moorin, individually

 

 

 

 

 

*

 

Alain Schreiber, individually

 

 

 

 

 

*

 

Joyce Tsang, individually

 

 

 

 

*By:

/s/ Pasquale DeAngelis

 

 

Pasquale DeAngelis, Attorney-in-Fact

 

 

 

Exhibit Index

SCHEDULE 13G

 

Exhibit Number

Exhibit Description

 

 

 

 

1

Joint Filing Agreement (previously filed)

 

2

Power of Attorney (previously filed)

 

 

 

 

Point Therapeutics (MM) (NASDAQ:POTP)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Point Therapeutics  (MM) Charts.
Point Therapeutics (MM) (NASDAQ:POTP)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Point Therapeutics  (MM) Charts.